Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location
N/A
VI-RADS was an observational, prospective, multicenter, no profit study. Th...
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
PHASE2
This phase II trial tests the effect of giving pembrolizumab in combination...
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
N/A
The study is intended to investigate whether the improved initial detection...
Status
Completed
Location
Stanford Cancer Center, Department of Urology
Start Date
2010-06
Trial ID
NCT01166230
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
NA
The Xpert BC Monitor is an mRNA-based urinary marker test for BC surveillan...